Ethacrynic Acid Tablet
Product Images NDC 68180-159

2 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ethacrynic Acid (NDC 68180-159). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (D0df415d Bc9d 44f4 Bca8 F7f3d8628619 01)

Image (D0df415d Bc9d 44f4 Bca8 F7f3d8628619 01)
Chemical structure of ethacrynic acid, showing a benzene ring with two chlorine atoms, a methoxy group, a carboxylic acid group, and an unsaturated ketone side chain.*
FDA Label Image

Image 3 (D0df415d Bc9d 44f4 Bca8 F7f3d8628619 02)

Image 3 (D0df415d Bc9d 44f4 Bca8 F7f3d8628619 02)
Label for Ethacrynic Acid Tablets, USP 25 mg oral tablets, by Lupin Pharmaceuticals, Inc. The label indicates 100 tablets per package, includes storage instructions to keep tightly closed at 20° to 25°C with permitted excursions, and notes the product is Rx only. Manufactured for Lupin Pharmaceuticals in Baltimore, MD, and manufactured by Lupin Limited in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.